Breast cancer statistics, 2017, racial disparity in mortality by state
2017/10/03 by Carol E. DeSantis, Carol DeSantis, Jiemin Ma +3 · 28 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Global Cancer Incidence and Screening #Breast Cancer Treatment Studies #Colorectal Cancer Screening and Detection
paper · pdf · doi:10.3322/caac.21412
Abstract
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 252,710 new cases of invasive breast cancer and 40,610 breast cancer deaths are expected to occur among US women in 2017. From 2005 to 2014, overall breast cancer incidence rates increased among Asian/Pacific Islander (1.7% per year), non-Hispanic black (NHB) (0.4% per year), and Hispanic (0.3% per year) women but were stable in non-Hispanic white (NHW) and American Indian/Alaska Native (AI/AN) women. The increasing trends were driven by increases in hormone receptor-positive breast cancer, which increased among all racial/ethnic groups, whereas rates of hormone receptor-negative breast cancers decreased. From 1989 to 2015, breast cancer death rates decreased by 39%, which translates to 322,600 averted breast cancer deaths in the United States. During 2006 to 2015, death rates decreased in all racial/ethnic groups, including AI/ANs. However, NHB women continued to have higher breast cancer death rates than NHW women, with rates 39% higher (mortality rate ratio [MRR], 1.39; 95% confidence interval [CI], 1.35-1.43) in NHB women in 2015, although the disparity has ceased to widen since 2011. By state, excess death rates in black women ranged from 20% in Nevada (MRR, 1.20; 95% CI, 1.01-1.42) to 66% in Louisiana (MRR, 1.66; 95% CI, 1.54, 1.79). Notably, breast cancer death rates were not significantly different in NHB and NHW women in 7 states, perhaps reflecting an elimination of disparities and/or a lack of statistical power. Improving access to care for all populations could eliminate the racial disparity in breast cancer mortality and accelerate the reduction in deaths from this malignancy nationwide. CA Cancer J Clin 2017;67:439-448. © 2017 American Cancer Society.
Citations
Cited by
- Age distributions of breast cancer diagnosis and mortality by race and ethnicity in US women
- Deep Angular Embedding and Feature Correlation Attention for Breast MRI Cancer Analysis
- Ductal carcinoma in situ of breast: update 2019
- Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment. [europepmc]
- Novel insights on m 6 A RNA methylation in tumorigenesis: a double-edged sword. [europepmc]
- Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. [europepmc]
- Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance. [europepmc]
- Diabetes, Obesity, and Breast Cancer. [europepmc]
- RET rearrangements are actionable alterations in breast cancer. [europepmc]
- The pro-metastasis effect of circANKS1B in breast cancer. [europepmc]
- CD36 plays a critical role in proliferation, migration and tamoxifen-inhibited growth of ER-positive breast cancer cells. [europepmc]
- Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. [europepmc]
- Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway. [europepmc]
- Epidemiological characteristics of and risk factors for breast cancer in the world. [europepmc]
- Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor-Positive Breast Cancer. [europepmc]
- Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis. [europepmc]
- microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. [europepmc]
- Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women. [europepmc]
- Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. [europepmc]
- Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer. [europepmc]
- A comprehensive analysis of racial disparities in chemical biomarker concentrations in United States women, 1999-2014. [europepmc]
- Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry. [europepmc]
- Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model. [europepmc]
- Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area. [europepmc]
- PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. [europepmc]
- An interpretable classifier for high-resolution breast cancer screening images utilizing weakly supervised localization. [europepmc]
- Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review). [europepmc]
- Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis. [europepmc]
Related